At corporate HQ, Amgen drops the axe

The pink slips are starting to go out at Amgen. In a follow-up to the biotech giant's announced restructuring, Amgen is laying off 675 of the 8,300 employees who work at its corporate headquarters in Thousand Oaks, CA. Amgen says it will lay off up to 14 percent of its workforce as it trims close to two billion dollars in costs. The restructuring was prompted by a drop in its revenue from lower sales of the anemia drug Aranesp.

- read the report from the San Jose Mercury News
- see Amgen's original announcement on the layoffs

ALSO: Dealing another blow to Amgen's fortunes, Medicare announced today that it won't reverse its decision to cut reimbursements for anemia drugs. Report

Related Articles:
Amgen discusses the future with analysts. Report
Amgen makes big workforce, budget cuts. Report
Major challenges loom for Amgen. Report
Amgen in crisis? Not us, says CEO Sharer. Report
Amgen layoffs: Good news for Ventura County? Report

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.